Klaim is a healthcare payments solutions provider located in the United Arab Emirates. To support its regional development aspirations, the company has obtained $10 million in Series A equity capital and an additional $16 million finance fund.
This investment will help it’s goal of changing the healthcare financial environment by improving cash flow for MENA healthcare providers and expediting the settlement of medical insurance claims.
Read also – Callio Therapeutics Raises US$187 Mn Series A Funding
With the money, it will increase its presence in the United Arab Emirates, invest in Saudi Arabia, Oman, and other areas, and keep improving its technology to better assist healthcare practitioners.
With the first deal under this effort scheduled for March 2025, it is further demonstrating its dedication to providing healthcare providers with cutting-edge solutions.
Karim Dakki, Co-Founder and CEO of Klaim, said: “Securing Series A funding is not only a major validation of our vision and business model but also the critical inflection point that enables us to scale rapidly.”
Through a partnership with Tharawat Tuwaiq Financial Company, an asset manager and financial adviser regulated by the Saudi Capital Market Authority (CMA), Klaim marked a major milestone in its growth into Saudi Arabia in 2024.
About Klaim
In 2019, Klaim launched as an innovative fintech company in the GCC, with a goal to change how healthcare providers handle finances worldwide. They set out to improve the medical claims reimbursement process, focusing on faster financial solutions.
At Klaim, they know the financial struggles healthcare providers face – the long wait, the uncertainty, and the complicated processes.
